Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer.
about
Leptin-Notch signaling axis is involved in pancreatic cancer progressionDelta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma.DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.Expression of Notch 1 receptor associated with tumor aggressiveness in papillary thyroid carcinoma.Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis.Notch Signaling Pathway in Pancreatic Cancer ProgressionThe anti-angiogenic effect of dexamethasone in a murine hepatocellular carcinoma model by augmentation of gluconeogenesis pathway in malignant cells.A bright future for protein kinase D1 as a drug target to prevent or treat pancreatic cancerElevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers.HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins.DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Concurrent Treatment with Anti-DLL4 Enhances Antitumor and Proapoptotic Efficacy of a γ-Secretase Inhibitor in Gastric Cancer.
P2860
Q30396675-D3C9AF36-3EA5-4FB4-A097-74B6934505D2Q33802846-96FBE6B5-8EAF-472F-AD76-DF7A0D3A7F99Q33915812-651BEC7D-7A76-4180-A64C-159CF8401B80Q35986858-1A86242D-0ABF-48DE-82A3-466ED7B187A3Q36394714-0A6F6F61-3BE4-4031-9143-9EC5F1CD6586Q36710074-CFDCDBC5-1180-4A34-B23C-A5F1CEA1A578Q36905854-EB2B724E-345A-4A1E-9467-80045223FEA8Q37156492-09BDC828-2C82-4BAB-859B-C82ADA18D1EDQ38778781-4FED35E6-816F-41AD-A61F-180623AD3EE9Q38852413-1A683BE7-9A38-4FCB-85BF-EA048067C4D3Q40029207-C99ECE94-3EFA-4331-82E5-F729715094B9Q41721768-4FBC8079-A249-4B80-B76E-D79CBA0F2AE0Q47144065-2E5D9EAF-3ED1-4517-84D0-96534C371011Q48308048-9E7BACD8-BE86-4D00-9496-A9870BE475ADQ51735938-B3AF68FA-DD56-4B1B-B6AA-682586542489
P2860
Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Delta like ligand 4 induces im ...... sistance in pancreatic cancer.
@en
Delta like ligand 4 induces im ...... sistance in pancreatic cancer.
@nl
type
label
Delta like ligand 4 induces im ...... sistance in pancreatic cancer.
@en
Delta like ligand 4 induces im ...... sistance in pancreatic cancer.
@nl
prefLabel
Delta like ligand 4 induces im ...... sistance in pancreatic cancer.
@en
Delta like ligand 4 induces im ...... sistance in pancreatic cancer.
@nl
P2093
P1433
P1476
Delta like ligand 4 induces im ...... sistance in pancreatic cancer.
@en
P2093
Biao Jiang
Daniel Chen
Muxing Kang
Qingqu Guo
Qiuping Xie
P356
10.1016/J.CANLET.2012.11.015
P407
P577
2012-11-27T00:00:00Z